London’s AIM Index continued its slide lower through Tuesday’s session, shedding just over nine points to reach 1013.19 at the bell, down just a whisker short of 200 points since the start of the year.
- Vast Resources +422%
- Borders & Southern +86%
- Senysne Health +23%
- Atome Energy -16%
- Hutchmed -14%
Anyone who recently bought into Vast Resources [LON:VAST] is likely to be cracking open a bottle tonight in the wake of the company’s 422% share price rise. A series of updates this morning have been well received by the market, but longer term investors will be mindful that the share price remains well below levels seen just a couple of years back. Given the company’s financing position, there’s little reason to believe these gains can necessarily be locked in.
Borders & Southern [LON:BOR] was the day’s second bigger riser, adding 86% by 4.30pm. The stock has been on the radar in recent weeks and bid speculation appears to be mounting further.
A notable mention for Sensyne Health [LON:SENS] which added 23% by the bell. Notification of stake building by a fund manager published this morning appears to have cemented support for the stock, which has been struggling since that boardroom shakeup and financing overhaul at the start of last month.
Atome Energy [LON:ATOM] was the day’s laggard, off 16% as the session concluded. Shares had a good run last week, but profit taking seems to be in play right now and the quoted spread is also accounting for much of the downside.
Hutchmed [LON:HCM] also languished, reaching the bell some 14% lower. The company this morning announced it has received an update from the US regulator stating that further trials are necessary for a new drug therapy – already permitted in China – to be considered for approval.
